Skip to main content

Funded Studies

The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.

Search or browse funded studies

Previously funded studies appear chronologically, with the most recent appearing first.

Filters
From
To
  • ${value}

Filter Results (2345${count})

  • Improved Biomarkers and Clinical Outcome Measures, 2018
    Does the Brain's Ability to Compensate for the Shortage of Dopamine Affect Parkinson's Disease Progression?

    Study Rationale:
    Parkinson's disease (PD) is a progressive disorder, but it is unclear what causes the gradual worsening of the symptoms over the years. It is also unknown why in some cases the disease...

  • Target Advancement Program, 2018
    Searching for Genes that Control Alpha-synuclein Levels in Parkinson's Disease

    Study Rationale:
    Alpha-synuclein is a sticky protein that clumps in the brains of people with Parkinson's disease (PD). The level of this protein in the brain correlates with the risk of Parkinson's...

  • Mitochondrial Biomarkers Program, 2018
    Developing Precision Biomarkers of Parkinson's Disease

    Study Rationale:
    Leucine-rich repeat kinase 2 (LRRK2) is the greatest known genetic contributor to Parkinson's disease (PD). Research studies have linked mutations (changes) in the LRRK2 gene to DNA...

  • Research Grant, 2018
    The Interplay between Genetic and Environmental Mechanisms in Parkinson’s Disease

    Study Rationale:
    Genes implicated in Parkinson's disease (PD), such as alpha-synuclein, DJ-1 and LRRK2, strongly influence the effect of environmental toxins, such as pesticide rotenone know to cause...

  • Research Grant, 2018
    Discovery of Microbiome Biomarkers for Parkinson's Disease

    Study Rationale:
    The gut microbiome -- a community of microorganisms living in the gastrointestinal tract -- influences the development of the nervous system, affects behavior and contributes to...

  • Target Advancement Program, 2018
    Hexosaminidase as a Therapeutic Target for Parkinson's Disease

    Study Rationale:
    Hexosaminidase (HEX) is a protein that is stored inside lysosomes, tiny bubbles inside the cell responsible for getting rid of its waste. A lack of HEX is associated with Sandhoff...

Two female doctors talking in the lab.

Apply for a Grant

Our funding programs support basic, translational and clinical research from academia and industry.

See Funding Opportunities
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.